VEGF Receptor 1 protein (Fc Chimera) (ab54258)
Constituents: PBS, pH 7.4
Our Abpromise guarantee covers the use of ab54258 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Biological Activity: The activity of sVEGFR 1/Fc was determined by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells. The ED 50 for this effect is typically 10-30 ng/ml.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- EC 18.104.22.168FLTFlt 1
- Flt-1Flt1Fms like tyrosine kinase 1Fms related tyrosine kinase 1Fms related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)Fms related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptorFms-like tyrosine kinase 1FRTSoluble VEGF receptor 1 14Soluble VEGFR1 variant 2Soluble VEGFR1 variant 21Tyrosine protein kinase FRTTyrosine protein kinase receptor FLTTyrosine-protein kinase FRTTyrosine-protein kinase receptor FLTVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 1 PrecursorVascular endothelial growth factor vascular permeability factor receptorVascular permeability factor receptorVascular permeability factor receptor 1VEGFR 1VEGFR-1VEGFR1VGFR1_HUMAN
Contains 7 Ig-like C2-type (immunoglobulin-like) domains.
Contains 1 protein kinase domain.
References for VEGF Receptor 1 protein (Fc Chimera) (ab54258)
This product has been referenced in:
- Kaczmarek MM et al. Assessment of VEGF-receptor system expression in the porcine endometrial stromal cells in response to insulin-like growth factor-I, relaxin, oxytocin and prostaglandin E2. Mol Cell Endocrinol 291:33-41 (2008). Read more (PubMed: 18562087) »